PPIDT00149
Drug Information
| Name | Romiplostim |
|---|---|
| Sequence | IEGPTLRQWLAARA |
| DrugBank_ID | DB05332 |
| Type | biotech |
| Indication | Treatment of chronic immune thrombocytopenic purpura. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, powder, for solution | Subcutaneous |
125 MCG
|
| Injection, powder, for solution | Subcutaneous |
250 MCG
|
| Injection, powder, for solution | Subcutaneous |
500 MCG
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
125 ug/0.25mL
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
250 ug/0.5mL
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
500 ug/1mL
|
| Powder, for solution | Subcutaneous |
250 mcg / vial
|
| Powder, for solution | Subcutaneous |
500 mcg / vial
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
62500000 mcg
|
| Injection, solution | — |
250 mcg
|
| Injection, solution | — |
500 mcg
|
| Injection, powder, lyophilized, for solution | Subcutaneous |
25000000 mcg
|
| Injection, powder, for solution | Subcutaneous |
250 mcg/1vial
|
| Injection, powder, for solution | Subcutaneous |
|
| Injection, powder, for solution | Subcutaneous |
250 mcg/0.5ml
|